Current Appointments & Affiliations
Associate Professor of Psychiatry and Behavioral Sciences
·
2025 - Present
Psychiatry & Behavioral Sciences, Adult Psychiatry & Psychology,
Psychiatry & Behavioral Sciences
Division Chief, Memory Disorders in the Department of Neurology
·
2019 - Present
Neurology,
Clinical Science Departments
Associate Professor in Neurology
·
2025 - Present
Neurology, Behavioral Neurology,
Neurology
Recent Publications
Recommended approaches to sharing individual research results in Alzheimer's disease research: A multidisciplinary expert Delphi consensus.
Journal Article J Alzheimers Dis · November 2025 BackgroundAs criteria for diagnosing Alzheimer's disease and Alzheimer's disease related dementias (AD/ADRD) evolves, AD-related biological measures of biomarkers (e.g., amyloid, tau) and genetic status (e.g., APOE) have gained heightened value in research ... Full text Link to item CiteSex Differences in Mortality and Health Care Utilization After Dementia Diagnosis.
Journal Article JAMA Neurol · October 1, 2025 IMPORTANCE: Sex differences may contribute to disparities in dementia outcomes. OBJECTIVE: To understand the association between sex and mortality and health care services use after dementia diagnosis. DESIGN, SETTING, AND PARTICIPANTS: This nationwide coh ... Full text Link to item CiteImplementation of an Alzheimer's Disease Blood Test: Adoption Experience by Memory Care Specialists in a Multi-Center Study.
Journal Article J Pers Med · October 1, 2025 Background/Objectives: A high-performing blood biomarker (BBM) test for Alzheimer's disease (AD) represents an accurate, accessible, and scalable tool to aid healthcare professionals (HCPs) evaluating patients presenting with signs or symptoms of mild cogn ... Full text Link to item CiteRecent Grants
Long-term Follow-up to Evaluate the Safety of LX1001 in Participants with APOE4 Homozygote Alzheimer's Disease.
Clinical TrialPrincipal Investigator · Awarded by LEXEO Therapeutics, Inc · 2024 - 2029A 6-month & 18-month prospective, randomized, placebo-controlled, double-blind dual clinical trial investigating efficacy and safety of buntanetap in treating participants of early Alzheimer's disea
Clinical TrialPrincipal Investigator · Awarded by Annovis Bio, Inc. · 2025 - 2028Biopsy-based single cell assays for olfactory sensory changes in an Alzheimer's Disease cohort
ResearchCo Investigator · Awarded by National Institute on Aging · 2024 - 2028View All Grants
Education, Training & Certifications
University of Pittsburgh, School of Medicine ·
1999
M.D.